RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 103 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $162 | -99.8% | 5,581 | -78.4% | 0.00% | – |
Q2 2022 | $107,000 | +143.2% | 25,890 | +564.0% | 0.00% | – |
Q1 2022 | $44,000 | +33.3% | 3,899 | +16.5% | 0.00% | – |
Q4 2021 | $33,000 | -63.7% | 3,348 | -24.0% | 0.00% | – |
Q3 2021 | $91,000 | -9.9% | 4,404 | -15.4% | 0.00% | – |
Q2 2021 | $101,000 | +1.0% | 5,204 | +10.3% | 0.00% | – |
Q1 2021 | $100,000 | -67.0% | 4,716 | -53.8% | 0.00% | – |
Q4 2020 | $303,000 | +194.2% | 10,200 | +113.2% | 0.00% | – |
Q3 2020 | $103,000 | +472.2% | 4,785 | +295.8% | 0.00% | – |
Q1 2020 | $18,000 | – | 1,209 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEA Management Company, LLC | 4,909,956 | $142,977,919 | 8.04% |
Opaleye Management Inc. | 735,000 | $21,403,200 | 7.44% |
Frazier Life Sciences Management, L.P. | 1,894,000 | $55,153,280 | 3.43% |
RA Capital Management | 5,516,067 | $160,627,871 | 3.26% |
Altium Capital Management LP | 170,000 | $4,950,400 | 2.52% |
Samsara BioCapital, LLC | 345,293 | $10,054,932 | 2.16% |
Rock Springs Capital Management LP | 1,760,865 | $51,276,389 | 1.23% |
Parkman Healthcare Partners LLC | 157,862 | $4,596,941 | 1.22% |
Baker Brothers Advisors | 6,354,608 | $185,046,185 | 1.11% |
EAM Investors, LLC | 164,695 | $4,795,918 | 0.99% |